Johnson & Johnson (JNJ) Stock Down 2% Today, Coronavirus Vaccine Not Ready Until Year-End
Johnson & Johnson (NYSE: JNJ) stock lost 5.64% on Friday and is 2.33% down today. The company’s CEO Alex Gorsky reassured that the company will have important data by the end of the year to offer a coronavirus vaccine.